Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.2, 2015-01, pp. : 400-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pazopanib for the Treatment of Soft Tissue Sarcoma – Where Does It Fit?

By Mallick Atrayee Basu Narasimhan Vivek Soman Neelesh Chawla Sant P

The Journal of OncoPathology, Vol. 2, Iss. 2, 2014-06 ,pp. : 59-63

Optimal Clinical Ltd

Access to resources Recommend Favorite

Metastatic Soft Tissue Sarcoma in Adults: Prognosis and Treatment Options

By Nielsen O.S.

American Journal of Cancer, Vol. 2, Iss. 3, 2003-01 ,pp. : 211-221

Adis International

Access to resources Recommend Favorite

Pazopanib: a promising new agent in the treatment of soft tissue sarcomas

By Kasper Bernd Hohenberger Peter

Future Oncology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1373-1383

Future Medicine

Access to resources Recommend Favorite

A unique radiation scheme for the treatment of high-grade non-metastatic soft tissue sarcoma: The Detroit Medical Center experience

By Fontanesi James

Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. : 141-145

Informa Healthcare

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I. Radford J.A. Harris M. Blay J.-Y. van Hoesel Q. le Cesne A. van Oosterom A.T. Clemons M.J. Kamby C. Hermans C. Whittaker J. Donato di Paola E. Verweij J. Nielsen S.

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite